Antoine Ferry
Chief Executive Officer at Laboratoires C.T.R.S. SAS
Network origin in Antoine Ferry first degree
Entity | Entity type | Industry | |
---|---|---|---|
Aterovax SA
Aterovax SA Medical/Nursing ServicesHealth Services Aterovax SA develops in vitro diagnostic products for the management and assessment of cardiovascular diseases. Its products include diagnostic blood tests for determining and measuring activity of the cardiovascular biomarkers secretory phospholipase A2 (sPLA2) and secretory phospholipase A2-IIA (sPLA2-IIA) which provide physicians clinical information about the presence of a destabilized atherosclerotic plaque. The company was founded by Alain Tedgui, Ziad Mallat, Philippe Gabriel Steg, Joelle Benessiano and Jean-Marie Freyssinet on June 29, 2006 and is headquartered in Paris, France.
6
| Holding Company | Medical/Nursing Services | 6 |
Gene Signal International SA
Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland.
5
| Private Company | Pharmaceuticals: Major | 5 |
Laboratoires C.T.R.S. SAS
Laboratoires C.T.R.S. SAS Pharmaceuticals: MajorHealth Technology Laboratoires C.T.R.S. SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Boulogne-Billancourt, France. The company was founded in 2002 by Bernard Deschamps. The CEO is Antoine Ferry.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Antoine Ferry via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CEVA Santé Animale SA
CEVA Santé Animale SA Pharmaceuticals: MajorHealth Technology CEVA Santé Animale SA develops and manufactures animal health products. It offers parasiticides, metabolism correctors, and pharmaceutical products for companion animals, ruminants, swine, and poultry. The company was founded in 1999 and is headquartered in Libourne, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Turenne Capital Partenaires SA
Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | President | |
Actelion Pharmaceuticals, Inc. (France)
Actelion Pharmaceuticals, Inc. (France) Industrial SpecialtiesProcess Industries Actelion Pharmaceuticals, Inc. (France) is a private company based in Le Pin, France. and has subsidiaries in France. Actelion Pharmaceuticals, Inc. manufactures insulation materials. The French company was founded by Annick Schwebig. | Industrial Specialties | Corporate Officer/Principal | |
Université de Montpellier | College/University | Doctorate Degree | |
THERADIAG | Medical Specialties | Corporate Officer/Principal | |
Université de Bordeaux | College/University | Graduate Degree | |
Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree | |
Laboratoire Cerba SA
Laboratoire Cerba SA Miscellaneous Commercial ServicesCommercial Services Laboratoire Cerba SA provides medical research services. It conducts tests in the fields of virology, autoimmune disease, allergy, endocrinology, oncology, toxicology and molecular genomics. The company was founded in 1967 and is headquartered in Saint-Ouen-l'Aumône, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Paris Jussieu | College/University | Doctorate Degree | |
Vauban Partenaires SA
Vauban Partenaires SA Investment ManagersFinance Vauban Partenaires SA (VP) is an independent boutique-sized private equity firm established in 1992 and based in Paris. Crédit Agricole SA (XP: ACA) is a significant minority shareholder. The firm operates in close relationship with their majority-owned subsidiary Participex Gestion, based in Lille in northern France. Both firms manage private equity funds including regional development funds. Their clients are leading financial institutions, regional banks and insurance companies. Their lead investors are regional subsidiaries of Crédit Agricole. | Investment Managers | Investment Committee Member | |
ALTUR INVESTISSEMENT | Investment Managers | Corporate Officer/Principal | |
UNICREDIT S.P.A. | Major Banks | Corporate Officer/Principal | |
Arterial Remodelling Technologies SA
Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman | |
FA Dièse SAS
FA Dièse SAS Investment ManagersFinance FA Dièse SAS is the Paris office of FA Dièse, a French private equity investment firm established in Bordeaux in 2001. The firm started operating in Paris in 2007. The shareholders of FA Dièse include business angels and entrepreneurs, as well as institutions such as banks, insurance companies and regional private equity funds. | Investment Managers | Private Equity Investor | |
NOVACYT | Medical Specialties | Founder | |
Gene Signal SAS
Gene Signal SAS Pharmaceuticals: GenericHealth Technology Gene Signal is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company's innovative therapies use precisely targeted angiogenic (inducing vascular growth) or angiostatic (inhibiting vascular growth) agents, derived from genes that are exclusively involved with the angiogenesis process . The firm's therapies aim to provide a more targeted alternative to existing solutions like Vascular Endothelial Growth Factors which impact other physiological phenomena in addition to angiogenesis. Gene Signal's targeted therapies represents a novel, next-generation approach to the management of angiogenesis based conditions and offer the potential to improve treatment options for concerned patients. Founded in 2000, Gene Signal has assembled an strong leadership team that includes scientific, medical, regulatory, and business professionals with successful track records in developing and bringing to market state of the art drugs. Gene Signal continues to develop its angiogenesis modulating technology and has built a significant intellectual property portfolio, as well as a robust clinical and preclinical pipeline. | Pharmaceuticals: Generic | Chief Executive Officer | |
Société Petroliere du Bec d'Ambes
Société Petroliere du Bec d'Ambes Miscellaneous Commercial ServicesCommercial Services Société Petroliere du Bec d'Ambes provides refrigerated storage facility services. The company is headquartered in Carbon-Blanc, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
Astra Zeneca Holding France SAS
Astra Zeneca Holding France SAS Pharmaceuticals: MajorHealth Technology Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BASF France SAS
BASF France SAS Chemicals: Major DiversifiedProcess Industries BASF France manufactures and markets coating products. The company is headquartered in Levallois-Perret, France. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Medtronic France SAS
Medtronic France SAS Medical/Nursing ServicesHealth Services Medtronic France SAS provides medical equipment and medical technology services. The company was founded by Earl Bakken and Palmer Hermundslie in 1949 and is headquartered in Boulogne-Billancourt, France. | Medical/Nursing Services | Corporate Officer/Principal | |
BIOM'UP | Medical Specialties | Director/Board Member | |
Nord Capital Partenaires SAS | Investment Managers | Chief Executive Officer | |
IÉSEG School of Management | College/University | Graduate Degree |
Statistics
International
France | 24 |
Italy | 2 |
Sectoral
Health Technology | 9 |
Finance | 7 |
Consumer Services | 6 |
Process Industries | 3 |
Commercial Services | 3 |
Operational
Corporate Officer/Principal | 12 |
Director/Board Member | 8 |
Chief Executive Officer | 6 |
Chairman | 5 |
Founder | 5 |
Most connected contacts
Insiders | |
---|---|
Benoît Pastour | 10 |
Eric Viaud | 9 |
Gérald Ulrich | 4 |
Thierry Bardon | 3 |
Jean Caraux | 3 |
Eric Thorin | 2 |
Marta Gehring | 1 |
Jean Pierre Decker | 1 |
Emmanuel Valentin | 1 |
Dominique Surun | 1 |
Bernard Deschamps | 1 |
- Stock Market
- Insiders
- Antoine Ferry
- Company connections